GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$76.23
Tradestie Score
49
Market Cap
$2.24B
Revenue Growth
0.3%
Analyst Upside
-3.6%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$98.77
|
$4.68B | 139.7 | 48 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$18.37
|
$4.60B | 32.7 | 46 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$85.27
|
$3.26B | - | 36 | Compare |
|
VCYT
Veracyte, Inc.
|
$40.87
|
$2.85B | 31.3 | 52 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.20
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$127.22
|
$1.77B | - | 46 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.66
|
$1.50B | - | 41 | Compare |
|
NEOG
Neogen Corp
|
$11.78
|
$1.26B | - | 46 | Compare |
|
OPK
Opko Health Inc.
|
$1.57
|
$1.23B | - | 43 | Compare |
|
NEO
NeoGenomics, Inc.
|
$17.32
|
$1.13B | - | 43 | Compare |
More GRAL Analysis
Data updated: Sep 11, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry